In the past it was necessary to utilise different secondary devices for therapeutic-apheresis depending on the type of therapy and the needed adsorber.The groundbreaking innovation from medicap clinic consists in the developmentof a highly flexible system, which enables in just one secondary-device the application and the precise management of different adsorbers. At the same time - and this is yet another crucial advantage - ADAsorb® is compatible to various primary separation systems. This development makes ADAsorb® the worldwide first open secondary-system for different plasma adsorbers and thus has been encountered with great interest amongst experts. ADAsorb® simplifies the procedure significantly and reduces investment costs considerably. The diversity of treatmentoptions enables a high efficiency of the device, thus serving both the patient and the operator.
ADAsorb® – Overview Features and Advantages
- Compact and highly flexible device.
- Applicable for various indications.
- Computer managed and monitored treatments.
- Specially developed treatment software for every single
- adsorber type.
- Clearly structured menu: simple and intuitive handling
- via touch screen monitor.
- The operator is guided step by step through the treatment
- with ADAsorb®.
- Easy adjustment of therapy parameters for an optimal
- adaption to each patient.
- Text messages and information offer a clear support.
- Information box: displays the data of all performed treatment cycles.
- Treatment protocol can be saved
- Graphical presentation of the extracorporeal ADAsorb® cycle ensures an overview any time.
Advantage Overview
Convincing innovative technology
First open apheresis system worldwide, which means variousadsorber types and technologies from differentmanufactures can be managed with ADAsorb®.
Flexibility, the way you want it
Application of different adsorbers and adsorber technologies.
Compatibility with diverse primary separation systems.
Efficiency that counts
Only one apheresis system necessary.
- reduced training time
- reduced staff
- reduced total costs
Following a range of established areas of application:
METABOLISM / LDL-Apheresis
- Familial hypercholesterolemia
- Elevated lipoprotein (a)
- Defect apolipoprotein B-100
NEPHROLOGY
RHEUMATOLOGY
- Systemic lupus erythematosus (SLE)
- Wegener´s granulomatosis
- Rheumatoid arthritis
TRANSPLANTATION
- HLA Hyperimmunisation
- Acute Humoral Rejection (AHR)
- AB0-incompatibility
CARDIOLOGY
- Delated Cardiomyopathy (DCM)
HAEMATOLOGY
- Acquired inhibitor against coagulation factor, i.e. Haemophilia with a factor VIII-Inhibitor
- Thrombotic Thrombocytopenic Purpura (TTP)
NEUROLOGY
- Guillain-Barré Syndrome (GBS)
- Myasthenia Gravis (MG)